The objective of this T32 training grant is to identify talented pre- and post-doctoral students and develop outstanding cancer biology researchers by placement in cancer biology laboratories that are conducting cutting edge research, development of a thorough cancer biology knowledge base with a thoughtfully constructed lecture schedule, and through skilled mentoring and evaluation. This Cancer Biology Training Grant (CBIO T32) is associated with a Cancer Biology Graduate Interdisciplinary Program (CBIO GIDP). The CBIO T32 has six predoctoral positions and four postdoctoral positions. Talented predoctoral students are admitted into the CBIO GIDP through an umbrella recruiting program and training grant eligible students in the CBIO GIDP are selected to be on the T32 through a competitive process. Postdoctoral trainees are selected through a competative process similar to that designed for predoctoral students. Students and trainees have 34 faculty researchers to choose from who are both skilled researchers and mentors. Our faculty are from 14 Departments and 5 different Colleges who provide a highly interdisciplinary and collaborative environment for our T32 appointees. Predoctoral student training involves didactic instruction in cancer causation, epidemiology and prevention and treatment through specific courses such as Basic Cancer Biology, Advanced Topics in Cancer Biology and our Cancer Biology Seminar Series. The Experimental Design and Grant Writing workshops are designed to complement the student's laboratory-based research and develop essential professional skills. Appreciation for the clinical challenges of cancer treatment is accomplished through a novel clinical experiences class taught by Cancer Center clinicians. The postdoctoral training program is more focused on laboratory-based research. However, postdoctoral trainees are also required to attend the CBIO seminars, attend both the Experimental Design and Grant Writing workshops, and to develop a career plan. Progress of students and trainees is ensured through regular mentoring committee meetings and annual evaluations by a progress committee. Our students and trainees emerge from this program with a thorough background in cancer biology and go on to become the next generation of cancer researchers who will be instrumental in preventing and curing human cancers.
The goal of this training grant continues to be the training of pre- and post-doctoral trainees in cancer biology research to find solutions to the problems associated with human cancer. The approach to this training involves didactic instruction, seminars, colloquia and laboratory-based research. The intent of the Cancer Biology T32 Training Program is to train the next generation of cancer researchers who will be successful in preventing and curing human cancers in the 21st century.
|Havas, Aaron P; Rodrigues, Kameron B; Bhakta, Anvi et al. (2016) Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma. Cancer Biol Ther 17:1240-1252|
|Akhenblit, Paul J; Hanke, Neale T; Gill, Alexander et al. (2016) Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI. Mol Imaging 15:|
|Centuori, Sara M; Gomes, Cecil J; Trujillo, Jesse et al. (2016) Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells. Biochim Biophys Acta 1861:663-70|
|Sroka, Isis C; Chopra, Harsharon; Das, Lipsa et al. (2016) Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin. J Cell Biochem 117:491-9|
|Yoshimaru, Eriko S; Randtke, Edward A; Pagel, Mark D et al. (2016) Design and optimization of pulsed Chemical Exchange Saturation Transfer MRI using a multiobjective genetic algorithm. J Magn Reson 263:184-92|
|Akhenblit, Paul J; Pagel, Mark D (2016) Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy. J Cancer Sci Ther 8:20-29|
|Remeniuk, Bethany; Sukhtankar, Devki; Okun, Alec et al. (2015) Behavioral and neurochemical analysis of ongoing bone cancer pain in rats. Pain 156:1864-73|
|Jaramillo, Melba C; Briehl, Margaret M; Batinic-Haberle, Ines et al. (2015) Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells. Free Radic Biol Med 83:89-100|
|Rausch, Matthew P; Hastings, Karen Taraszka (2015) An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen. PLoS One 10:e0123332|
|Alizadeh, Darya; Larmonier, Nicolas (2014) Chemotherapeutic targeting of cancer-induced immunosuppressive cells. Cancer Res 74:2663-8|
Showing the most recent 10 out of 107 publications